Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder with progressive ataxia that affects both the peripheral and central nervous system (CNS). While later CNS neuropathology involves loss of large principal neurons and glutamatergic and GABAergic synaptic terminals in the cerebellar dentate nucleus, early pathological changes in FRDA cerebellum remain largely uncharacterized. Here, we report early cerebellar VGLUT1 (SLC17A7)-specific parallel fiber (PF) synaptic deficits and dysregulated cerebellar circuit in the frataxin knock-in/knockout (KIKO) FRDA mouse model. At asymptomatic ages, VGLUT1 levels in cerebellar homogenates are significantly decreased, whereas VGLUT2 (SLC17A6) levels are significantly increased, in KIKO mice compared with age-matched controls. Additionally, GAD65 (GAD2) levels are significantly increased, while GAD67 (GAD1) levels remain unaltered. This suggests early VGLUT1-specific synaptic input deficits, and dysregulation of VGLUT2 and GAD65 synaptic inputs, in the cerebellum of asymptomatic KIKO mice. Immunohistochemistry and electron microscopy further show specific reductions of VGLUT1-containing PF presynaptic terminals in the cerebellar molecular layer, demonstrating PF synaptic input deficiency in asymptomatic and symptomatic KIKO mice. Moreover, the parvalbumin levels in cerebellar homogenates and Purkinje neurons are significantly reduced, but preserved in other interneurons of the cerebellar molecular layer, suggesting specific parvalbumin dysregulation in Purkinje neurons of these mice. Furthermore, a moderate loss of large principal neurons is observed in the dentate nucleus of asymptomatic KIKO mice, mimicking that of FRDA patients. Our findings thus identify early VGLUT1-specific PF synaptic input deficits and dysregulated cerebellar circuit as potential mediators of cerebellar dysfunction in KIKO mice, reflecting developmental features of FRDA in this mouse model.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769605PMC
http://dx.doi.org/10.1242/dmm.030049DOI Listing

Publication Analysis

Top Keywords

kiko mice
20
early vglut1-specific
12
deficits dysregulated
12
dysregulated cerebellar
12
cerebellar circuit
12
mouse model
12
synaptic input
12
cerebellar
10
parallel fiber
8
fiber synaptic
8

Similar Publications

Recently a novel genetically modified mouse strain with serum carboxylesterase knocked-out and the human acetylcholinesterase gene knocked-in (KIKO) was created to simulate human responses to nerve agent (NA) exposure and its standard medical treatment. A adenosine receptor (AAR) agonist N-bicyclo-(2.2.

View Article and Find Full Text PDF

ECHS1 Deficiency (ECHS1D) is a rare and devastating pediatric disease that currently has no defined treatments. This disorder results from missense loss-of-function mutations in the gene that result in severe developmental delays, encephalopathy, hypotonia, and early death. ECHS1 enzymatic activity is necessary for the beta-oxidation of fatty acids and the oxidation of branched-chain amino acids within the inner mitochondrial matrix.

View Article and Find Full Text PDF
Article Synopsis
  • Organophosphoate (OP) chemicals inhibit the enzyme acetylcholinesterase (AChE), making it challenging to study OP poisoning due to animals' natural resistance from serum carboxylesterase.
  • * A new genetically modified mouse strain, KIKO, was created to lack serum carboxylase and to express a human-like AChE protein, providing a better model for OP research.
  • * In the study, KIKO mice showed increased acetylcholine levels after OP exposure, and the presence of a reactive countermeasure in the brain was detected, highlighting the potential of these mice for developing OP antidotes.*
View Article and Find Full Text PDF

Introduction: Indole-3-carbinol (I3C) is found in cruciferous vegetables and used as a dietary supplement. It is known to act as a ligand for aryl hydrocarbon receptor (AhR). In the current study, we investigated the role of AhR and the ability of I3C to attenuate LPS-induced Acute Respiratory Distress Syndrome (ARDS).

View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on optimizing a next-generation HIV-1 vaccine using engineered gp140 envelope trimers (sC23v4 KIKO and ConCv5 KIKO) that can effectively display on cell surfaces through various delivery methods.
  • - Key modifications to enhance vaccine efficacy included altering the cleavage site, introducing a membrane-binding element from another virus (VSV-G), and engineering the trimer structure to maintain its native-like conformation.
  • - Test results indicated that the ConCv5 KIKO trimer had better structural stability and elicited strong immune responses, especially when combined with specific DNA and protein boost regimens in immunized mice, leading to robust CD4 T cell activation and generating a range of antibodies against HIV-
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!